The story of Viagra presents a intricate picture for shareholders. While the initial launch generated significant returns, the end of its exclusive rights opened the floodgates to off-brand alternatives, dramatically https://hyperbookmarks.com/story21623238/the-copyright-and-the-pharmaceutical-industry-a-precarious-opportunity